
Board Meeting13 Nov 2026, 07:01 pm
Natural Capsules Ltd Approves Preferential Allotment of Shares & Warrants
AI Summary
Natural Capsules Ltd announced that its Board of Directors, in a meeting held on November 13, 2026, approved the unaudited consolidated and standalone financial results for the quarter and half-yearly ended September 30, 2026. Additionally, the Board approved the preferential allotment of 1,12,500 equity shares at ₹178.00 per share, aggregating to ₹2,00,25,000, and 4,50,000 warrants at ₹178.00 per warrant, aggregating to ₹8,01,00,000. These allotments are in accordance with SEBI regulations and will rank pari-passu with existing equity shares. The company will seek listing approval for the allotted shares in due course.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Approved preferential allotment of 1,12,500 equity shares.
- Approved allotment of 4,50,000 convertible warrants.
- Total value of equity shares allotted is ₹2,00,25,000.
- Total value of warrants allotted is ₹8,01,00,000.
Price Impact
More from NATCAPSUQ